Morgan Stanley increased its stake in Corcept Therapeutics, and Norges Bank also bought a new stake in the company.

The entities involved

• Corcept Therapeutics →

  American pharmaceutical company

  • Corcept Therapeutics made required filings with the SEC regarding institutional holdings on June 16, 2026.Mon 03:27
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• Norges Bank →

  central bank of Norway

  • Norges Bank bought a new position in Qualcomm shares, coinciding with buy ratings and price targets from TD Cowen, reported by MarketBeat.Mon 06:47
  • Norges Bank acquired a new stake in Brunswick Corporation.Mon 04:46

Related events

• Celcuity Inc. and Corcept Therapeutics are noted for developing targeted therapies in the United States.Jun 8
• Investor activity regarding Corcept Therapeutics, including RBC boosting holdings and Amundi buying, was disclosed via SEC filings.Aug 26
• Corcept Therapeutics and Twist Bioscience are noted as holdings within the First Trust biotech fund.Aug 19
• Corcept Therapeutics is seeking final approval from the European Commission for a cancer therapy already approved in the US market.Sep 22
• Corcept Therapeutics disclosed insider trading activity via SEC filings.Sep 4